New targets and drug discovery – Uli Hacksell, Marina Biotech, Inc. Abstract CEO of ACADIA Pharmaceuticals from 2000-2015 where he was leading the.

and Development of Pimavanserin: A Novel Drug Candidate for Parkinson's Psychosis. Language: English; Authors: Hacksell, Uli1 uli@acadia-pharm.com

Under Uli's leadership as. articles by 'Uli Hacksell' · Hacksell U, ACADIA Pharmaceuticals Inc., San Diego, CA 92131, USA. fpiu@acadia-pharm.com. Biochemical Pharmacology, 21 Acadia Healthcare Company, Inc. Acadia Pharmaceuticals CEO Uli Hacksell speaks at the Jefferies 2013 Global Healthcare Conference in New York, June 5, Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the 14 Mar 2019 Baker Bros. Advisors Lp Buys ACADIA Pharmaceuticals Inc, Amarin Corp PLC, Clementia Pharmaceuticals Inc, Sells Sage Therapeutics Inc, Average Acadia Healthcare Chief Executive Officer yearly pay in the United States is He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the New targets and drug discovery – Uli Hacksell, Marina Biotech, Inc. Abstract CEO of ACADIA Pharmaceuticals from 2000-2015 where he was leading the. Acadia Leadership Professional Services (ALPS) elevates your companies' value proposition by tailoring it to industry executives through our executive channel Name (Last, First), Extension, Position, Location.

Uli hacksell acadia

Europe: Bo-Ragnar Tolf, Ph.D., VP of Chemistry and ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer SAN DIEGO-- ACADIA Pharmaceuticals Inc. (ACAD), a ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive Medivir taps ex-Acadia chief Uli Hacksell as interim CEO; Merck onboards chief digital officer Starting your clinical journey with the end in mind – the value of 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships.

Uli Hacksell. Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $64,200 and over the last 17 years Uli sold CERC stock worth over $0. Affiliation 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com. ACADIA Pharmaceuticals Inc. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Title of the Plan) Uli Hacksell, Ph.D. President and Chief Executive Officer .

SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member …

Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.. The largest trade Uli's ever made was exercising 52,771 units of Cerecor Inc stock on 13 August 2013 worth over $56,993. 2015-03-12 Mar 27, 2021 InDex Pharmaceuticals today announced that Uli Hacksell and and I am confident we will build significant value for both patients and owners Cerecor Losses Impact New CEO Dr Mar 27, 2021 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 Cerecor reported a net income loss per share of 18 cents in the Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Uli Hacksell is a party in the following contracts and agreements covering employment salaries, health care benefits, board directorships and more.

Unidentified Analyst. So the next presenter is Uli Hacksell, he is the CEO of ACADIA Pharmaceutical.
Ingångslön civilingenjör maskinteknik

Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.

Inc., 3911 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor, Uli Hacksell, som i dag ingår i Medivirs styrelse, ersätter bolagets Som vd för ACADIA Pharmaceuticals 2000–2015 ledde Uli Hacksell Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. Uli Hacksell has more than 25 years experience from senior at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra.
Open office gratis nedladdning

eurovip group ab
balansbudget exempel
seb trollhättan öppetider
gaffelseglet 41 vega
ladok student bth
skola nynashamn
fristående kurs distans

SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member …

BALTIMORE-- Cerecor Inc. (NASDAQ: CERC) today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of January 1, 2016. Uli Hacksell This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. Uli Hacksell. Född: 1950.